Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Brightlands Venture Partners (BVP) is an investment organization founded in 2004. It is based in Europe and focuses on investing in innovative companies that address global structural challenges in essential societal systems, specifically in the sectors of health, agrifood, and renewable chemistry.
BVP invests in breakthrough technologies with proprietary foundations that have the potential to fundamentally improve essential systems. The organization targets innovative solutions that address root causes, demonstrate technical defensibility, and are designed for real-world application, particularly in complex or regulated environments. BVP primarily invests in Seed to Series A stages, with initial ticket sizes ranging from €250,000 to €2 million, focusing on companies based in Europe.
Notable portfolio companies include Fortimedix Surgical, Qorium, Kipster, Vivalyx, ReSolved Technologies, Psylaris, PL BioScience, Grassa, Circularise, Corporis Medical, S&dB, and EnzyPep. These companies are involved in shaping the future of health, agrifood, and renewable chemistry.
To approach Brightlands Venture Partners, founders should visit their website at brightlandsventurepartners.com for pitching guidelines and further information.
Brightlands Venture Partners primarily invests in Seed to Series A stages.
The firm invests between €250,000 and €2 million.
BVP focuses on healthcare, agtech, and renewable chemistry sectors.
Brightlands Venture Partners targets companies based in Europe.
Founders can pitch Brightlands Venture Partners through their website at brightlandsventurepartners.com.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.